Lichtenfels, M., Fontana, V., Nyland, F. H., Marques, B. S., Schorr, M. C., Marcolin, J. C., … Pedrini, J. L. (2026). What happens in residual disease after neoadjuvant chemotherapy? Efficacy of a novel in vitro breast cancer chemoresistance platform to demonstrate high resistance to drugs. Mastology, 33(suppl.1). https://doi.org/10.29289/259453942023V33S1010